journal article·2021-07-14

Supramolecular Antagonists Promote Mitochondrial Dysfunction

Mingming Li, Yanqiu Song, Na Song, Guangyao Wu, Hao Zhou, Jiafu Long, Pengcheng Zhang, Linqi Shi, Zhilin Yu

Nano Letters· Volume 21· Issue 13
Publisher page

Abstract

Mitochondrion-targeting therapy exhibits great potential in cancer therapy but significantly suffers from limited therapeutic efficiency. Here we report on mitochondrion-targeting supramolecular antagonist-inducing tumor cell death via simultaneously promoting cellular apoptosis and preventing survival. The supramolecular antagonist was created via coassembly of a mitochondrion-targeting pentapeptide with its two derivatives functionalized with a BH3 domain or the drug camptothecin (CPT). While drug CPT released from the antagonist induced cellular apoptosis via decreasing the mitochondrial membrane potential, the BH3 domain prevented cellular survival through facilitating the association between the supramolecular antagonists and antiapoptotic proteins, thereby initiating mitochondrial permeabilization. Both in vitro and in vivo studies confirmed the combinatorial therapeutic effect arising from the BH3 domain and CPT drug within the supramolecular antagonist on cell death and thereby inhibiting tumor growth. Our findings demonstrate an efficient combinatorial mechanism for mitochondrial dysfunction, thus potentially serving as novel organelle-targeting medicines.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: ATP Synthase and ATPases Research · Mitochondrial Function and Pathology · Boron Compounds in Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Functional Polymer Materials, Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Institute of Polymer Chemistry, College of Chemistry, Nankai University, Weijin Road 94, Tianjin 300071, China

Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Science, College of Life Sciences, Nankai University, Weijin Road 94, Tianjin 300071, China

State Key Laboratory of Drug Research & Center for Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China

Funding

National Natural Science Foundation of China · The Fundamental Research Funds for the Central Universities

References (41)

Show source-provided references
1. 10.1016/j.cell.2012.02.03510.1016/j.cell.2012.02.035 ↗
2. 10.1002/adma.20180272510.1002/adma.201802725 ↗
3. 10.1021/acs.accounts.6b0027710.1021/acs.accounts.6b00277 ↗
4. 10.1021/acs.chemrev.7b0004210.1021/acs.chemrev.7b00042 ↗
5. 10.1002/anie.20191582610.1002/anie.201915826 ↗
6. 10.1016/j.addr.2020.09.01010.1016/j.addr.2020.09.010 ↗
7. 10.1021/jacs.6b0978310.1021/jacs.6b09783 ↗
8. 10.1038/s41467-017-00047-z10.1038/s41467-017-00047-z ↗
9. 10.1021/jacs.8b0772710.1021/jacs.8b07727 ↗
10. 10.1002/adma.20030038310.1002/adma.200300383 ↗
11. 10.1039/c0cs00152j10.1039/c0cs00152j ↗
12. 10.1039/C7CS00521K10.1039/C7CS00521K ↗
13. 10.1021/acs.chemrev.7b0052210.1021/acs.chemrev.7b00522 ↗
14. 10.1016/j.addr.2016.08.00610.1016/j.addr.2016.08.006 ↗
15. 10.1002/adma.20170344410.1002/adma.201703444 ↗
16. 10.1039/C7CS00877E10.1039/C7CS00877E ↗
17. 10.1016/j.addr.2020.10.00910.1016/j.addr.2020.10.009 ↗
18. 10.1016/j.biomaterials.2009.01.01010.1016/j.biomaterials.2009.01.010 ↗
19. 10.1038/nchem.192010.1038/nchem.1920 ↗
20. 10.1021/acs.accounts.6b0053310.1021/acs.accounts.6b00533 ↗
21. 10.1021/jacs.8b0491210.1021/jacs.8b04912 ↗
22. 10.1002/anie.20191308710.1002/anie.201913087 ↗
23. 10.1002/anie.20200629010.1002/anie.202006290 ↗
24. 10.1021/jacs.9b1223210.1021/jacs.9b12232 ↗
25. 10.1007/s11095-016-1930-410.1007/s11095-016-1930-4 ↗
26. 10.1039/C9SC01410A10.1039/C9SC01410A ↗
27. 10.1021/acs.nanolett.9b0313610.1021/acs.nanolett.9b03136 ↗
28. 10.1016/j.nantod.2020.10087810.1016/j.nantod.2020.100878 ↗
29. 10.1002/1521-3757(20011015)113:20<3922::AID-ANGE3922>3.0.CO;2-810.1002/1521-3757(20011015)113:20<3922::AID-ANGE3922>3.0.CO;2-8 ↗
30. 10.1021/sb200002m10.1021/sb200002m ↗
31. 10.1074/jbc.272.17.1135010.1074/jbc.272.17.11350 ↗
32. 10.1038/nrc197710.1038/nrc1977 ↗
33. 10.1038/sj.cdd.440074010.1038/sj.cdd.4400740 ↗
34. 10.1002/anie.20180971610.1002/anie.201809716 ↗
35. 10.1002/bip.36010110210.1002/bip.360101102 ↗
36. 10.1039/c3cs60048c10.1039/c3cs60048c ↗
37. 10.1038/ncomms109310.1038/ncomms1093 ↗
38. 10.1002/anie.20120426810.1002/anie.201204268 ↗
39. 10.1073/pnas.88.9.367110.1073/pnas.88.9.3671 ↗
40. 10.1016/j.biomaterials.2012.07.02510.1016/j.biomaterials.2012.07.025 ↗
41. 10.1007/s11010-010-0709-x10.1007/s11010-010-0709-x ↗